Arkolith/Insider Trading/TMCI/Form 4/A

Treace John T.

Chief Executive Officer, Director, 10% OwnerTREACE MEDICAL CONCEPTS, INC. (TMCI) · full profile →Form 4/A · filed Jun 12, 2026
Net Buying
Open-Market Buys
$99K
Open-Market Sells
$0
Net Open-Market Flow
$99K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 11, 2026Buy(P)10K$4.04$40K7.3M
Jun 10, 2026Buy(P)15K$4.02$59K7.3M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001193125-26-268606) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML